NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED)
Who is NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED)?
Our purpose is to proactively reduce harm from new and emerging drugs. We do this by producing research into interventions and translating research into evidence-based information. Funded by the Commonwealth Department of Health, NCCRED is made up of a consortium: - The National Centre for Educat...See more
Industry & Specialities
Market Research
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Address:
22-32 KING ST; RANDWICK, NEW SOUTH WALES 2031, AU
Employees by Department
- IT / Product (1)
- The Rest (10)
- Total (11)
Key Decision Makers
Dora Karavasilis
Knowledge Translation Lead
Jemma Hallen
Centre (Project) Manager
Penny Hill
Adjunct Fellow
Lucy Watson
Knowledge Translation Lead
Employees by Seniority
C-level
0employees
Senior
2employees
Non-managers
5employees
Financials
LOW
spending power
Funding Status
Private
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Similar industry
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- What is the funding status of NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED)?
- Where is NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED)'s headquarter?
- What NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED)'s spending power?
- Does NATIONAL CENTRE FOR CLINICAL RESEARCH ON EMERGING DRUGS (NCCRED) have a presence in the domain it operates in?